Browse By Oncolytic Virus Species Result Page of OvirusTdb

The Total number of records shown on this page is 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_1123Reoviruswild typeRNAReoviridaeNoneYesNoNoATCCCervical cancer cell lineHeLaS31.0E+5 cells per wellNAFluoroscent mesure at 450nm1MOI25% cell viabilityNoNoNA No responseApoptosis induction in cancer cell linesNANA15958641
OV_1124Reoviruswild typeRNAReoviridaeNoneYesNoNoATCCCervical cancer cell lineC33A1.0E+5 cells per wellNAFluoroscent mesure at 450nm0.01MOI40% cell viabilityNoNoNA No responseApoptosis induction in cancer cell linesNANA15958641
OV_1125Reoviruswild typeRNAReoviridaeNoneYesNoNoATCCCervical cancer cell lineC33A1.0E+5 cells per wellNAFluoroscent mesure at 450nm0.1MOI25% cell viabilityNoNoNA No responseApoptosis induction in cancer cell linesNANA15958641
OV_1126Reoviruswild typeRNAReoviridaeNoneYesNoNoATCCCervical cancer cell lineC33A1.0E+5 cells per wellNAFluoroscent mesure at 450nm1MOI5% cell viabilityNoNoNA No responseApoptosis induction in cancer cell linesNANA15958641
OV_1127Reoviruswild typeRNAReoviridaeNoneYesNoNoHamamatsu university school of medicine, japanOvarian cancer cell lineHOC-11.0E+5 cells per wellNAFluoroscent mesure at 450nm0.01MOI80% cell viabilityNoNoNA No responseApoptosis induction in cancer cell linesNANA15958641
OV_1128Reoviruswild typeRNAReoviridaeNoneYesNoNoHamamatsu university school of medicine, japanOvarian cancer cell lineHOC-11.0E+5 cells per wellNAFluoroscent mesure at 450nm0.1MOI50% cell viabilityNoNoNA No responseApoptosis induction in cancer cell linesNANA15958641
OV_1129Reoviruswild typeRNAReoviridaeNoneYesNoNoHamamatsu university school of medicine, japanOvarian cancer cell lineHOC-11.0E+5 cells per wellNAFluoroscent mesure at 450nm1MOI35% cell viabilityNoNoNA No responseApoptosis induction in cancer cell linesNANA15958641
OV_1130Reoviruswild typeRNAReoviridaeNoneYesNoNoTsukuba University, JapanOvarian cancer cell lineHAC-21.0E+5 cells per wellNAFluoroscent mesure at 450nm0.01MOI35% cell viabilityNoNoNA No responseApoptosis induction in cancer cell linesNANA15958641
OV_1131Reoviruswild typeRNAReoviridaeNoneYesNoNoTsukuba University, JapanOvarian cancer cell lineHAC-21.0E+5 cells per wellNAFluoroscent mesure at 450nm0.1MOI25% cell viabilityNoNoNA No responseApoptosis induction in cancer cell linesNANA15958641
OV_1132Reoviruswild typeRNAReoviridaeNoneYesNoNoTsukuba University, JapanOvarian cancer cell lineHAC-21.0E+5 cells per wellNAFluoroscent mesure at 450nm1MOI10% cell viabilityNoNoNA No responseApoptosis induction in cancer cell linesNANA15958641
OV_1133Reoviruswild typeRNAReoviridaeNoneYesNoNoOsaka Medical college, japanOvarian cancer cell lineOMC-31.0E+5 cells per wellNAFluoroscent mesure at 450nm0.01MOI10% cell viabilityNoNoNA No responseApoptosis induction in cancer cell linesNANA15958641
OV_1134Reoviruswild typeRNAReoviridaeNoneYesNoNoOsaka Medical college, japanOvarian cancer cell lineOMC-31.0E+5 cells per wellNAFluoroscent mesure at 450nm0.1MOI10% cell viabilityNoNoNA No responseApoptosis induction in cancer cell linesNANA15958641
OV_1135Reoviruswild typeRNAReoviridaeNoneYesNoNoOsaka Medical college, japanOvarian cancer cell lineOMC-31.0E+5 cells per wellNAFluoroscent mesure at 450nm1MOI5% cell viabilityNoNoNA No responseApoptosis induction in cancer cell linesNANA15958641
OV_1443ReovirusReoT3DRNAReoviridaeNoneYesNoNoNCIHuman NSCLC cell lineNCIH460NANAXTT assayLog10 pfu/cell20% cell survived 48 hours after post infectionNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1444ReovirusReoT3DRNAReoviridaeNoneYesNoNoNCIHuman NSCLC cell lineA549NANAXTT assayLog10 pfu/cellLess than 10% cell survived 48 hours after post infectionNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1445ReovirusReoT3DRNAReoviridaeNoneYesNoNoNCIHuman NSCLC cell lineHOP-62NANAXTT assayLog10 pfu/cell20% cell survived 48 hours after post infectionNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1446ReovirusReoT3DRNAReoviridaeNoneYesNoNoNCIHuman NSCLC cell lineH322MNANAXTT assayLog10 pfu/cell70% cell survived 48 hours after post infectionNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1447ReovirusReoT3DRNAReoviridaeNoneYesNoNoNCIHuman NSCLC cell lineH226NANAXTT assayLog10 pfu/cell70% cell survived 48 hours after post infectionNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1448ReovirusReoT3DRNAReoviridaeNoneYesNoNoNCIHuman NSCLC cell lineEKVXNANAXTT assayLog10 pfu/cell30% cell survived 48 hours after post infectionNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1449ReovirusReoT3DRNAReoviridaeNoneYesNoNoNCIHuman NSCLC cell lineNCI-H23NANAXTT assayLog10 pfu/cell20% cell survived 48 hours after post infectionNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1450ReovirusReoT3DRNAReoviridaeNoneYesNoNoNCIHuman NSCLC cell lineNCI-H522NANAXTT assayLog10 pfu/cellLess than 10% cell survived 48 hours after post infectionNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1451ReovirusReoT3DRNAReoviridaeNoneYesNoNoNCIHuman NSCLC cell lineHOP-92NANAXTT assayLog10 pfu/cell30% cell survived 48 hours after post infectionNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1452ReovirusReoT3DRNAReoviridaeNoneNoVirus strain in combination with palcitaxel (100 micromolar)NoNCIHuman NSCLC cell lineNCIH460NANADose response analysis curveLog10 pfu/cell100% cell death after 4 daysNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1453ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.003 +/- 0.001 micromolar, 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.903 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1454ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (38.50 +/- 16.01 micromolar, 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.144 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1455ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.08 +/- 0.04 micromolar, 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.577 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1456ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (56.06 +/- 15.87 micromolar, 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.294 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1457ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (77.79 +/- 25.08 micromolar, 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.543 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1458ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (>100 micromolar, 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.069 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1459ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.003 +/- 0.001 micromolar, 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.221NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1460ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (38.50 +/- 16.01 micromolar, 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.295NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1461ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.08 +/- 0.04 micromolar, 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.303NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1462ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (56.06 +/- 15.87 micromolar, 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.440NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1463ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (77.79 +/- 25.08 micromolar, 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.344NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1464ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (>100 micromolar, 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.092NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1465ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.003 +/- 0.001 micromolar, 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.057NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1466ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (38.50 +/- 16.01 micromolar, 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.613NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1467ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.08 +/- 0.04 micromolar, 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.159NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1468ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (56.06 +/- 15.87 micromolar, 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.660NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1469ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (77.79 +/- 25.08 micromolar, 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.218NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1470ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (>100 micromolar, 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.133NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1471ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.003 +/- 0.001 micromolar, 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.193 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1472ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (38.50 +/- 16.01 micromolar, 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.178 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1473ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.08 +/- 0.04 micromolar, 1:200)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.329 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1474ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (56.06 +/- 15.87 micromolar, 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.124 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1475ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (77.79 +/- 25.08 micromolar, 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.004 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1476ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (>100 micromolar, 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.078 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1477ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.003 +/- 0.001 micromolar, 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.042NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1478ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (38.50 +/- 16.01 micromolar, 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.420NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1479ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.08 +/- 0.04 micromolar, 1:200)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.061NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1480ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (56.06 +/- 15.87 micromolar, 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.216NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1481ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (77.79 +/- 25.08 micromolar, 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 1 × 10⁴ NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1482ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (>100 micromolar, 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.081NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1483ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.003 +/- 0.001 micromolar, 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.013NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1484ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (38.50 +/- 16.01 micromolar, 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.994NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1485ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.08 +/- 0.04 micromolar, 1:200)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.011NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1486ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (56.06 +/- 15.87 micromolar, 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.374NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1487ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (77.79 +/- 25.08 micromolar, 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 4 × 10⁶ NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1488ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (>100 micromolar, 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.084NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1489ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (5.31+/-1.21, ratio is 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.875NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1490ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (6.82+/- 3.22, ratio is 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.352NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1491ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (3.51+/- 1.15, ratio is 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.579NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1492ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (29.34+/- 6.62, ratio is 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.955NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1493ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (14.71+/- 6.60, ratio is 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.615NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1494ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (>100, ratio is 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1495ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (5.31+/-1.21, ratio is 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75% death at CI value 0.313NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1496ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (6.82+/- 3.22, ratio is 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell75% death at CI value 0.325NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1497ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (3.51+/- 1.15, ratio is 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell75% death at CI value 0.487NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1498ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (29.34+/- 6.62, ratio is 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell75% death at CI value 0.559NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1499ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (14.71+/- 6.60, ratio is 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell75% death at CI value 0.297NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1500ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (>100, ratio is 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell75% death at CI value >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1501ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (5.31+/-1.21, ratio is 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.112NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1502ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (6.82+/- 3.22, ratio is 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.500NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1503ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (3.51+/- 1.15, ratio is 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.530NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1504ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (29.34+/- 6.62, ratio is 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.328NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1505ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (14.71+/- 6.60, ratio is 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.145NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1506ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (>100, ratio is 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1507ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (5.31+/-1.21, ratio is 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.061NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1508ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (6.82+/- 3.22, ratio is 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.053NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1509ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (3.51+/- 1.15, ratio is 1:200)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.546NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1510ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (29.34+/- 6.62, ratio is 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.933NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1511ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (14.71+/- 6.60, ratio is 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.558NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1512ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (>100, ratio is 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1513ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (5.31+/-1.21, ratio is 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell75% death at CI value 0.006NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1514ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (6.82+/- 3.22, ratio is 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell75% death at CI value 0.099NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1515ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (3.51+/- 1.15, ratio is 1:200)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell75% death at CI value 0.207NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1516ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (29.34+/- 6.62, ratio is 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell75% death at CI value >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1517ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (14.71+/- 6.60, ratio is 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell75% death at CI value 0.057NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1518ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (>100, ratio is 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell75% death at CI value >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1519ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (5.31+/-1.21, ratio is 1:533)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.129NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1520ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (6.82+/- 3.22, ratio is 1:200)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.195NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1521ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (3.51+/- 1.15, ratio is 1:200)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.342NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1522ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (29.34+/- 6.62, ratio is 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.610NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1523ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (14.71+/- 6.60, ratio is 1:200)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.013NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1524ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (>100, ratio is 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1525ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.01+/- 0.003, 1:53)NoNCIHuman NSCLC cell lineNCIH460NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.199NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1526ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.83+/- 0.61, 1:20)NoNCIHuman NSCLC cell lineHOP-92NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.372NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1527ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.02+/- 0.01, 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.630NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1528ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1529ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (17.69+/- 10.16, 1:20)NoNCIHuman NSCLC cell lineH226NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.112NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950